Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Addictive genes and the relationship to obesity and inflammation.

Heber D, Carpenter CL.

Mol Neurobiol. 2011 Oct;44(2):160-5. doi: 10.1007/s12035-011-8180-6. Epub 2011 Apr 19. Review.

2.
3.

Reward deficiency syndrome: genetic aspects of behavioral disorders.

Comings DE, Blum K.

Prog Brain Res. 2000;126:325-41. Review.

PMID:
11105655
4.

Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E, Giordano J, Morse S, Gold M.

Postgrad Med. 2009 Nov;121(6):176-96. doi: 10.3810/pgm.2009.11.2087. Review.

5.
6.

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE.

J Psychoactive Drugs. 2000 Nov;32 Suppl:i-iv, 1-112. Review.

PMID:
11280926
7.

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE.

Pharmacogenetics. 1995 Jun;5(3):121-41. Review.

PMID:
7550364
8.

Neural systems implicated in obesity as an addictive disorder: from biological to behavioral mechanisms.

Schulte EM, Yokum S, Potenza MN, Gearhardt AN.

Prog Brain Res. 2016;223:329-46. doi: 10.1016/bs.pbr.2015.07.011. Epub 2015 Oct 23. Review.

PMID:
26806784
9.

The addictive dimensionality of obesity.

Volkow ND, Wang GJ, Tomasi D, Baler RD.

Biol Psychiatry. 2013 May 1;73(9):811-8. doi: 10.1016/j.biopsych.2012.12.020. Epub 2013 Jan 29. Review.

10.

The role of dopamine in motivation for food in humans: implications for obesity.

Wang GJ, Volkow ND, Fowler JS.

Expert Opin Ther Targets. 2002 Oct;6(5):601-9. Review.

PMID:
12387683
11.

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M.

Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Review.

12.

The addictive brain: all roads lead to dopamine.

Blum K, Chen AL, Giordano J, Borsten J, Chen TJ, Hauser M, Simpatico T, Femino J, Braverman ER, Barh D.

J Psychoactive Drugs. 2012 Apr-Jun;44(2):134-43. Review.

PMID:
22880541
13.
14.

Dual roles of dopamine in food and drug seeking: the drive-reward paradox.

Wise RA.

Biol Psychiatry. 2013 May 1;73(9):819-26. doi: 10.1016/j.biopsych.2012.09.001. Epub 2012 Oct 5. Review.

15.

Obesity and its relationship to addictions: is overeating a form of addictive behavior?

Barry D, Clarke M, Petry NM.

Am J Addict. 2009 Nov-Dec;18(6):439-51. doi: 10.3109/10550490903205579. Review.

16.

Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.

Bowirrat A, Oscar-Berman M.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):29-37. Review.

PMID:
15457501
17.

Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?

Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M.

Mol Neurobiol. 2015 Dec;52(3):1862-1869. doi: 10.1007/s12035-015-9110-9. Epub 2015 Mar 10. Review.

18.

Overlap of food addiction and substance use disorders definitions: analysis of animal and human studies.

Hone-Blanchet A, Fecteau S.

Neuropharmacology. 2014 Oct;85:81-90. doi: 10.1016/j.neuropharm.2014.05.019. Epub 2014 May 24. Review.

PMID:
24863044
19.

Is obesity an inflammatory condition?

Das UN.

Nutrition. 2001 Nov-Dec;17(11-12):953-66. Review.

PMID:
11744348
20.

Ghrelin signalling and obesity: at the interface of stress, mood and food reward.

Schellekens H, Finger BC, Dinan TG, Cryan JF.

Pharmacol Ther. 2012 Sep;135(3):316-26. doi: 10.1016/j.pharmthera.2012.06.004. Epub 2012 Jun 27. Review.

PMID:
22749794

Supplemental Content

Support Center